000			03305nam a22002897a 4500
003			OSt
005			20240404105316.0
008			240404b |||||||| |||| 00| 0 eng d
020			_a9351525724
020			_a978-9351525721
082			_a616.462 _bDHC
100			_aDhinakaran T, _91554
245			_aClinical Approach to Renal Diseases in Diabetes / _cby Dhinakaran T (Author) / _hEng
250			_a1st ed.
260			_aNew Delhi : _bJaypee Brothers Medical Publishers , _c2015.
300			_axv, 226 p.; _c25 cm.
500			_aRenal disease is a major complication in diabetes and one of the major causes of end-stage renal failure. Clinical Approach to Renal Diseases in Diabetes highlights the development of diabetes mellitus, renal involvement and other comorbid conditions along with the latest therapeutic regimens. This book is comprised of 12 chapters, which discuss a range of topics in detail including diabetic kidney disease, risk factors for diabetic nephropathy, pathophysiology of diabetic nephropathy, microalbuminuria in diabetic nephropathy, diabetic nephropathy treatment, hyperglycaemia control, treatment of hypertension, proteinuria therapy, diabetic nephropathy and cardiovascular morbidity. The preventability of diabetic nephropathy is debated, including the prevention of microalbuminuria through renin angiotensin system, inhibitor therapy and the role of biomarkers in diabetic nephropathy. Clinical Approach to Renal Diseases in Diabetes covers all aspects of renal involvement in diabetes, providing a useful resource to general practitioners, urologists, nephrologists and diabetologists. Key Points Comprehensive guide covers all elements of renal involvement in diabetesIncludes debate on the preventability of diabetic nephropathy45 full colour illustrations and tables
501			_aThis book focuses on the renal complications associated with diabetes. The first chapter provides an overview of the current scenario with respect to diabetes in the world and India in particular, factors contributing to the development of diabetes as well as measures to prevent it. The subsequent chapters deal with diabetic kidney disease (DKD), risk factors and pathophysiology of DKD. The use of microalbuminuria as a biomarker to monitor the development and progression of DKD as well as the possibility of prevention in early stages are described. Chapters 7 to 9 describe therapeutic measures including hyperglycemia control, hypertension and proteinuria therapy as well as diet control (protein and salt restriction), cessation of smoking, weight reduction and dyslipidemia therapy. Newer therapeutic approaches are also described. The last three chapters describe other clinical manifestations of diabetic kidney disease, cardiovascular morbidity and end stage renal disease (ESRD) and their management.
505			_rT Dhinakaran, Madurai Kidney Centre and Transplantation Research Institute, Madurai, Tamil Nadu, India; Southern Chapter Indian Society of Nephrology, India; Nephrology Association of Tamilnadu and Puducherry, Tamil Nadu, India
650			_amadhumeh _91555
650			_aDiabetes _91556
650			_aDiabetes treatment _91557
650			_aAyurveda _91558
650			_aNephrology _91559
700			_aDhinakaran T, _91554
942			_2ddc _cBK
999			_c33987 _d33987